Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy

INTRODUCTION: Allogeneic hematopoietic cell transplantation (allo-HCT) offers a potential cure for high-risk hematological malignancy; however, long-term survivors experience increased cardiovascular morbidity and mortality. It is unclear how allo-HCT impacts cardiovascular function in the short-ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillon, Hayley T., Foulkes, Stephen, Horne-Okano, Yuki A., Kliman, David, Dunstan, David W., Daly, Robin M., Fraser, Steve F., Avery, Sharon, Kingwell, Bronwyn A., La Gerche, Andre, Howden, Erin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797839/
https://www.ncbi.nlm.nih.gov/pubmed/36588564
http://dx.doi.org/10.3389/fcvm.2022.926064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797839/
https://www.ncbi.nlm.nih.gov/pubmed/36588564
http://dx.doi.org/10.3389/fcvm.2022.926064

Ejemplares similares